User profiles for H. Lim

Henry W. Lim

- Verified email at hfhs.org - Cited by 33695

Hyeontaek Lim

- Verified email at google.com - Cited by 7988

Ho-Jin Lim

- Verified email at knu.ac.kr - Cited by 6510

Molecular cues to implantation

SK Dey, H Lim, SK Das, J Reese, BC Paria… - Endocrine …, 2004 - academic.oup.com
Successful implantation is the result of reciprocal interactions between the implantation-competent
blastocyst and receptive uterus. Although various cellular aspects and molecular …

[HTML][HTML] Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and …

…, J Chung, EJ Ha, J Kim, YH Lee, HK Lim… - Korean journal of …, 2016 - ncbi.nlm.nih.gov
The rate of detection of thyroid nodules and carcinomas has increased with the widespread
use of ultrasonography (US), which is the mainstay for the detection and risk stratification of …

Long‐term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta‐analysis

…, AG Brooks, P Kuklik, DH Lau, HS Lim… - Journal of the …, 2013 - Am Heart Assoc
Background In the past decade, catheter ablation has become an established therapy for
symptomatic atrial fibrillation ( AF ). Until very recently, few data have been available to guide …

Palm: Scaling language modeling with pathways

…, L Fedus, D Zhou, D Ippolito, D Luan, H Lim… - Journal of Machine …, 2023 - jmlr.org
… , h], where h is the attention head size. Here, the key/value projections are shared for each
head, ie “key” and “value” are projected to [1,h], but “query” is still projected to shape [k, h… -m/h, …

[HTML][HTML] Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma

…, C Huang, S Mulla, Y Wang, HY Lim… - … England Journal of …, 2020 - Mass Medical Soc
Background The combination of atezolizumab and bevacizumab showed encouraging
antitumor activity and safety in a phase 1b trial involving patients with unresectable …

Palm 2 technical report

…, B Lee, E Li, M Li, W Li, YG Li, J Li, H Lim, H Lin… - arXiv preprint arXiv …, 2023 - arxiv.org
We introduce PaLM 2, a new state-of-the-art language model that has better multilingual and
reasoning capabilities and is more compute-efficient than its predecessor PaLM. PaLM 2 is …

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

…, S Negrier, YC Ou, D Castellano, HY Lim, H Uemura… - The Lancet, 2011 - thelancet.com
Background The treatment of advanced renal cell carcinoma has been revolutionised by
targeted therapy with drugs that block angiogenesis. So far, no phase 3 randomised trials …

[PDF][PDF] Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

…, TCY Tsao, M Pless, T Muller, HL Lim… - Journal of clinical …, 2004 - researchgate.net
… Pereira, Filippo De Marinis, Joachim von Pawel, Ulrich Gatzemeier, Thomas Chang Yao
Tsao, Miklos Pless, Thomas Muller, Hong-Liang Lim, Christopher Desch, Klara Szondy …

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases

…, A Tyagi, SR Desai, LE French, HW Lim… - Journal of the American …, 2021 - Elsevier
Background Cutaneous reactions after messenger RNA (mRNA)-based COVID-19 vaccines
have been reported but are not well characterized. Objective To evaluate the morphology …

[HTML][HTML] Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma

…, M Ikeda, PR Galle, M Ducreux, TY Kim, HY Lim… - Journal of …, 2022 - Elsevier
Background & Aims IMbrave150 demonstrated that atezolizumab plus bevacizumab led to
significantly improved overall survival (OS) and progression-free survival (PFS) compared …